NIH-funded research NIH-funded research

Improving techniques to analyze proteins in human cells

Official title: Advancing top-down proteomics with capillary electrophoresis-mass spectrometry

Funded at Michigan State University · NIH-11080248 · Data updated 2026-11-12

This study is exploring new ways to look at proteins in individual human cells to find important clues about how cancer spreads and how our bodies develop, which could help improve tests and treatments for patients with colorectal cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMichigan State University
NIH-funded
Lab location1 site (East Lansing, United States)
Project startMay 1, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$400,534
NIH project number5R35GM153479-02
Project IDNIH-11080248 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with colorectal cancer or those interested in the biological mechanisms of cancer and development.

Less likely to help

Patients with conditions unrelated to cancer or developmental biology may not receive direct benefits from this research.

What this research studies

This research focuses on developing advanced techniques using capillary electrophoresis-mass spectrometry (CE-MS) to analyze proteins in human cells. By enhancing the ability to identify and characterize proteins at a single-cell level, the research aims to uncover important biological information related to developmental processes and cancer. Specifically, it seeks to identify new biomarkers for colorectal cancer metastasis and understand protein roles during early embryonic development. Patients may benefit from insights gained through this research, which could lead to improved diagnostic and therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to the discovery of new biomarkers for colorectal cancer, improving early detection and treatment options for patients.

How similar studies have gone: Other research has shown success in using advanced proteomics techniques to identify biomarkers, suggesting that this approach has the potential for significant findings.

Where this research is happening

  • Michigan State University
    East Lansing, United States
    Active

Researchers

  • Principal investigator: Sun, Liangliang — Michigan State University
  • Study coordinator: Sun, Liangliang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.